Neuregulin-1 Enhances Depolarization-Induced GABA Release

Neuron

Volumn 54, Issue 4, 2007, Pages 599-610

  Woo, Ran Sook ^a   Li, Xiao Ming ^a,b   Tao, Yanmei ^a   Carpenter Hyland, Ezekiel ^a   Huang, Yang Z ^c   Weber, Janet ^d   Neiswender, Hannah ^a   Dong, Xian Ping ^a   Wu, Jiong ^e   Gassmann, Martin ^f   Lai, Cary ^d   Xiong, Wen Cheng ^a   Gao, Tian Ming ^b   Mei, Lin ^a,b  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b SOUTHERN MEDICAL UNIVERSITY   (China)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

^d SCRIPPS RESEARCH INSTITUTE   (United States)

^e CELL SIGNALING TECHNOLOGY   (United States)

^f UNIVERSITY OF BASEL   (Switzerland)

Author keywords

HUMDISEASE; MOLNEURO; SYSNEURO

Indexed keywords

4 AMINOBUTYRIC ACID; EPIDERMAL GROWTH FACTOR RECEPTOR 4; MUTANT PROTEIN; NEU DIFFERENTIATION FACTOR; PRESYNAPTIC RECEPTOR;

4 AMINOBUTYRIC ACID RELEASE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EMBRYO; GENETIC SUSCEPTIBILITY; HUMAN; HUMAN CELL; MALE; NERVE CELL MEMBRANE STEADY POTENTIAL; NERVE ENDING; NEUROMODULATION; NEUROTRANSMISSION; NONHUMAN; NUCLEOTIDE SEQUENCE; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RAT; REGULATORY MECHANISM; SCHIZOPHRENIA;

ANIMALS; ANIMALS, NEWBORN; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; ENZYME INHIBITORS; GAMMA-AMINOBUTYRIC ACID; GLUTAMATE DECARBOXYLASE; GLUTAMIC ACID; GREEN FLUORESCENT PROTEINS; HIPPOCAMPUS; IN SITU HYBRIDIZATION; INHIBITORY POSTSYNAPTIC POTENTIALS; NEUREGULIN-1; NEURONS; PATCH-CLAMP TECHNIQUES; POTASSIUM CHLORIDE; PRESYNAPTIC TERMINALS; RATS; RECEPTOR, EPIDERMAL GROWTH FACTOR; TRANSFECTION;

EID: 34248547353     PISSN: 08966273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuron.2007.04.009     Document Type: Article

References (49)

1. Adlkofer K., and Lai C. Role of neuregulins in glial cell development. Glia 29 (2000) 104-111
2. Anton E.S., Ghashghaei H.T., Weber J.L., McCann C., Fischer T.M., Cheung I.D., Gassmann M., Messing A., Klein R., Schwab M.H., et al. Receptor tyrosine kinase ErbB4 modulates neuroblast migration and placement in the adult forebrain. Nat. Neurosci. 7 (2004) 1319-1328
3. Belan P.V., and Kostyuk P.G. Glutamate-receptor-induced modulation of GABAergic synaptic transmission in the hippocampus. Pflugers Arch. 444 (2002) 26-37
4. Buonanno A., and Fischbach G.D. Neuregulin and ErbB receptor signaling pathways in the nervous system. Curr. Opin. Neurobiol. 11 (2001) 287-296
5. Canas N., Pereira I.T., Ribeiro J.A., and Sebastiao A.M. Brain-derived neurotrophic factor facilitates glutamate and inhibits GABA release from hippocampal synaptosomes through different mechanisms. Brain Res. 1016 (2004) 72-78
6. Citri A., and Yarden Y. EGF-ERBB signalling: towards the systems level. Nat. Rev. Mol. Cell Biol. 7 (2006) 505-516
7. Corfas G., Roy K., and Buxbaum J.D. Neuregulin 1-erbB signaling and the molecular/cellular basis of schizophrenia. Nat. Neurosci. 7 (2004) 575-580
8. Coyle J.T. The GABA-glutamate connection in schizophrenia: which is the proximate cause?. Biochem. Pharmacol. 68 (2004) 1507-1514
9. Fischbach G.D., and Rosen K.M. ARIA: a neuromuscular junction neuregulin. Annu. Rev. Neurosci. 20 (1997) 429-458
10. Flames N., Long J.E., Garratt A.N., Fischer T.M., Gassmann M., Birchmeier C., Lai C., Rubenstein J.L., and Marin O. Short- and long-range attraction of cortical GABAergic interneurons by neuregulin-1. Neuron 44 (2004) 251-261
11. Frerking M., Malenka R.C., and Nicoll R.A. Brain-derived neurotrophic factor (BDNF) modulates inhibitory, but not excitatory, transmission in the CA1 region of the hippocampus. J. Neurophysiol. 80 (1998) 3383-3386
12. Fukazawa R., Miller T.A., Kuramochi Y., Frantz S., Kim Y.D., Marchionni M.A., Kelly R.A., and Sawyer D.B. Neuregulin-1 protects ventricular myocytes from anthracycline-induced apoptosis via erbB4-dependent activation of PI3-kinase/Akt. J. Mol. Cell. Cardiol. 35 (2003) 1473-1479
13. Fukui N., Muratake T., Kaneko N., Amagane H., and Someya T. Supportive evidence for neuregulin 1 as a susceptibility gene for schizophrenia in a Japanese population. Neurosci. Lett. 396 (2006) 117-120
14. Garcia R.A., Vasudevan K., and Buonanno A. The neuregulin receptor ErbB-4 interacts with PDZ-containing proteins at neuronal synapses. Proc. Natl. Acad. Sci. USA 97 (2000) 3596-3601
15. Gerlai R., Pisacane P., and Erickson S. Heregulin, but not ErbB2 or ErbB3, heterozygous mutant mice exhibit hyperactivity in multiple behavioral tasks. Behav. Brain Res. 109 (2000) 219-227
16. Golub M.S., Germann S.L., and Lloyd K.C. Behavioral characteristics of a nervous system-specific erbB4 knock-out mouse. Behav. Brain Res. 153 (2004) 159-170
17. Gu Z., Jiang Q., Fu A.K., Ip N.Y., and Yan Z. Regulation of NMDA receptors by neuregulin signaling in prefrontal cortex. J. Neurosci. 25 (2005) 4974-4984
18. Hashimoto T., Volk D.W., Eggan S.M., Mirnics K., Pierri J.N., Sun Z., Sampson A.R., and Lewis D.A. Gene expression deficits in a subclass of GABA neurons in the prefrontal cortex of subjects with schizophrenia. J. Neurosci. 23 (2003) 6315-6326
19. Hippenmeyer S., Shneider N.A., Birchmeier C., Burden S.J., Jessell T.M., and Arber S. A role for neuregulin1 signaling in muscle spindle differentiation. Neuron 36 (2002) 1035-1049
20. Holmes W.E., Sliwkowski M.X., Akita R.W., Henzel W.J., Lee J., Park J.W., Yansura D., Abadi N., Raab H., Lewis G.D., et al. Identification of heregulin, a specific activator of p185erbB2. Science 256 (1992) 1205-1210
21. Hosak L., and Libiger J. Antiepileptic drugs in schizophrenia: a review. Eur. Psychiatry 17 (2002) 371-378
22. Huang Y.Z., Won S., Ali D.W., Wang Q., Tanowitz M., Du Q.S., Pelkey K.A., Yang D.J., Xiong W.C., Salter M.W., and Mei L. Regulation of neuregulin signaling by PSD-95 interacting with ErbB4 at CNS synapses. Neuron 26 (2000) 443-455
23. Huang Y.Z., Wang Q., Xiong W.C., and Mei L. Erbin is a protein concentrated at postsynaptic membranes that interacts with PSD-95. J. Biol. Chem. 276 (2001) 19318-19326
24. Kim J.W., Lee Y.S., Cho E.Y., Jang Y.L., Park D.Y., Choi K.S., Jeun H.O., Cho S.H., Jang S.Y., and Hong K.S. Linkage and association of schizophrenia with genetic variations in the locus of neuregulin 1 in Korean population. Am. J. Med. Genet. B. Neuropsychiatr. Genet. 141 (2006) 281-286
25. Kwon O.B., Longart M., Vullhorst D., Hoffman D.A., and Buonanno A. Neuregulin-1 reverses long-term potentiation at CA1 hippocampal synapses. J. Neurosci. 25 (2005) 9378-9383
26. Lai C., and Lemke G. An extended family of protein-tyrosine kinase genes differentially expressed in the vertebrate nervous system. Neuron 6 (1991) 691-704
27. Lambert N.A., and Wilson W.A. Temporally distinct mechanisms of use-dependent depression at inhibitory synapses in the rat hippocampus in vitro. J. Neurophysiol. 72 (1994) 121-130
28. Law A.J., Shannon Weickert C., Hyde T.M., Kleinman J.E., and Harrison P.J. Neuregulin-1 (NRG-1) mRNA and protein in the adult human brain. Neuroscience 127 (2004) 125-136
29. Law A.J., Kleinman J.E., Weinberger D.R., and Weickert C.S. Disease associated intronic variants in the erbb4 gene are related to altered erbb4 splice variant expression in the brain in schizophrenia. Hum. Mol. Genet. 16 (2006) 129-141 10.1093/hmg/ddl449 Published online December 12, 2006
30. Li B., Woo R.S., Mei L., and Malinow R. The neuregulin 1 receptor ErbB4 controls glutamatergic synapse maturation and plasticity. Neuron 54 (2007) 583-597 this issue
31. Ma L., Huang Y.Z., Pitcher G.M., Valtschanoff J.G., Ma Y.H., Feng L.Y., Lu B., Xiong W.C., Salter M.W., Weinberg R.J., and Mei L. Ligand-dependent recruitment of the ErbB4 signaling complex into neuronal lipid rafts. J. Neurosci. 23 (2003) 3164-3175
32. McBain C.J., and Fisahn A. Interneurons unbound. Nat. Rev. Neurosci. 2 (2001) 11-23
33. Mountcastle V.B., Talbot W.H., Sakata H., and Hyvarinen J. Cortical neuronal mechanisms in flutter-vibration studied in unanesthetized monkeys. Neuronal periodicity and frequency discrimination. J. Neurophysiol. 32 (1969) 452-484
34. Nicodemus K.K., Luna A., Vakkalanka R., Goldberg T., Egan M., Straub R.E., and Weinberger D.R. Further evidence for association between ErbB4 and schizophrenia and influence on cognitive intermediate phenotypes in healthy controls. Mol. Psychiatry 11 (2006) 1062-1065
35. Ohnuma T., Augood S.J., Arai H., McKenna P.J., and Emson P.C. Measurement of GABAergic parameters in the prefrontal cortex in schizophrenia: focus on GABA content, GABA(A) receptor alpha-1 subunit messenger RNA and human GABA transporter-1 (HGAT-1) messenger RNA expression. Neuroscience 93 (1999) 441-448
36. Oliva Jr. A.A., Jiang M., Lam T., Smith K.L., and Swann J.W. Novel hippocampal interneuronal subtypes identified using transgenic mice that express green fluorescent protein in GABAergic interneurons. J. Neurosci. 20 (2000) 3354-3368
37. Pillai-Nair N., Panicker A.K., Rodriguiz R.M., Gilmore K.L., Demyanenko G.P., Huang J.Z., Wetsel W.C., and Maness P.F. Neural cell adhesion molecule-secreting transgenic mice display abnormalities in GABAergic interneurons and alterations in behavior. J. Neurosci. 25 (2005) 4659-4671
38. Ren X.R., Ming G.L., Xie Y., Hong Y., Sun D.M., Zhao Z.Q., Feng Z., Wang Q., Shim S., Chen Z.F., et al. Focal adhesion kinase in netrin-1 signaling. Nat. Neurosci. 7 (2004) 1204-1212
39. Si J., Luo Z., and Mei L. Induction of acetylcholine receptor gene expression by ARIA requires activation of mitogen-activated protein kinase. J. Biol. Chem. 271 (1996) 19752-19759
40. Simmons D.M., Arriza J.L., and Swanson L.W. A complete protocol for in situ hybridization of messenger RNAs in brain and other tissues with radiolabeled single-stranded RNA probes. J. Histotechnol. 12 (1989) 169-181
41. Stefansson H., Sigurdsson E., Steinthorsdottir V., Bjornsdottir S., Sigmundsson T., Ghosh S., Brynjolfsson J., Gunnarsdottir S., Ivarsson O., Chou T.T., et al. Neuregulin 1 and susceptibility to schizophrenia. Am. J. Hum. Genet. 71 (2002) 877-892
42. Stefansson H., Sarginson J., Kong A., Yates P., Steinthorsdottir V., Gudfinnsson E., Gunnarsdottir S., Walker N., Petursson H., Crombie C., et al. Association of neuregulin 1 with schizophrenia confirmed in a Scottish population. Am. J. Hum. Genet. 72 (2003) 83-87
43. Tafoya L.C., Mameli M., Miyashita T., Guzowski J.F., Valenzuela C.F., and Wilson M.C. Expression and function of SNAP-25 as a universal SNARE component in GABAergic neurons. J. Neurosci. 26 (2006) 7826-7838
44. Tidcombe H., Jackson-Fisher A., Mathers K., Stern D.F., Gassmann M., and Golding J.P. Neural and mammary gland defects in ErbB4 knockout mice genetically rescued from embryonic lethality. Proc. Natl. Acad. Sci. USA 100 (2003) 8281-8286
45. Turner T.J., and Goldin S.M. Multiple components of synaptosomal [3H]-gamma-aminobutyric acid release resolved by a rapid superfusion system. Biochemistry 28 (1989) 586-593
46. Woo R.S., Park E.Y., Shin M.S., Jeong M.S., Zhao R.J., Shin B.S., Kim C.J., Park J.W., and Kim K.W. Mechanism of nicotine-evoked release of 3H-noradrenaline in human cerebral cortex slices. Br. J. Pharmacol. 137 (2002) 1063-1070
47. Yang J.Z., Si T.M., Ruan Y., Ling Y.S., Han Y.H., Wang X.L., Zhou M., Zhang H.Y., Kong Q.M., Liu C., et al. Association study of neuregulin 1 gene with schizophrenia. Mol. Psychiatry 8 (2003) 706-709
48. Yau H.J., Wang H.F., Lai C., and Liu F.C. Neural development of the neuregulin receptor ErbB4 in the cerebral cortex and the hippocampus: preferential expression by interneurons tangentially migrating from the ganglionic eminences. Cereb. Cortex 13 (2003) 252-264
49. Zhu X., Lai C., Thomas S., and Burden S.J. Neuregulin receptors, erbB3 and erbB4, are localized at neuromuscular synapses. EMBO J. 14 (1995) 5842-5848